Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-28 pm EDT 		5-day change 1st Jan Change
807.9 USD +0.05% Intraday chart for Eli Lilly and Company +3.15% +38.59%
May. 28 Annual sales of weight-loss drugs seen hitting $150 billion RE
May. 28 Weight-loss drug forecasts jump to $150 billion as supply grows RE

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Previsiones de venta de medicamentos para adelgazar suben a 150.000 millones de dólares
Umsätze mit Abnehmspritzen schießen in den nächsten Jahren weiter in die Höhe
Weight-loss drug forecasts jump to $150 billion as supply grows
Le bric-à-brac de Zonebourse : Ubisoft démarre fort, Broadcom dans le sillage de Nvidia
Sector Update: Health Care Stocks Decline Late Friday Afternoon
Eli Lilly to Invest Another $5.3 Billion in Indiana Manufacturing Site
Sector Update: Health Care Stocks Softer in Friday Afternoon Trading
Sector Update: Health Care
Top Midday: Intuit, Workday Shares Tumble on Lowered Guidance; Ozempic Reduces Kidney Disease Events, Deaths From Cardiovascular Causes; NHTSA Finds 9 Additional Incidents Tied to Waymo
Eli Lilly More Than Doubles Investment in Indiana Manufacturing Site to $9 Billion
Eli Lilly More Than Doubles Investment in Indiana Manufacturing Site to $9 Billion
Eli Lilly : investit 5,3 Mds$ dans son site de l'Indiana
Eli Lilly and Company Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production forirzepatide and Pipeline Medicines
ETFs para adelgazar, y la revancha de Apple
Le bric-à-brac de Zonebourse : ETF amaigrissants, Europlasma et revanche d'Apple
Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln
Swiss Equities Tumble as UK Inflation Data Dampens June Rate Cut Hopes
Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro
Two US asset managers launch weight-loss ETFs
Eli Lilly : essai concluant dans la maladie de Crohn
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. News Eli Lilly and Company
  5. Other languages